GlobeNewswire PharmaOriginal article
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
Data ReadoutpositiveTelomir-ZnPositive
AI Analysis
Summary
Telomir announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth through iron modulation in triple-negative breast cancer and prostate cancer models.
Outcome Details
Peer-reviewed preclinical data demonstrate Telomir-Zn suppresses tumor growth through iron modulation in TNBC and prostate cancer models
Importance:4/10
Sentiment:
0.60
preclinicalpublicationtumor suppressioniron modulationTNBCprostate cancer
Read the original article
Published by GlobeNewswire Pharma on August 10, 2026 12:00 PM